94135-19-0 Usage
Uses
Used in Polymer Production:
2,6-dimethylbenzene-1,3,5-triamine is used as a crosslinking agent in the production of polymers such as nylon, polyurethane, and epoxy resins. Its ability to form crosslinks enhances the mechanical properties and durability of these materials.
Used as a Curing Agent for Epoxy Resins:
In the epoxy resin industry, 2,6-dimethylbenzene-1,3,5-triamine serves as a curing agent, facilitating the hardening process of the resin. This role is crucial for the manufacturing of coatings, adhesives, and composite materials that require high strength and chemical resistance.
Used as a Corrosion Inhibitor:
2,6-dimethylbenzene-1,3,5-triamine is utilized as a corrosion inhibitor in various applications, protecting metal surfaces from degradation and extending the service life of equipment and structures.
Check Digit Verification of cas no
The CAS Registry Mumber 94135-19-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,1,3 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 94135-19:
(7*9)+(6*4)+(5*1)+(4*3)+(3*5)+(2*1)+(1*9)=130
130 % 10 = 0
So 94135-19-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H13N3/c1-4-6(9)3-7(10)5(2)8(4)11/h3H,9-11H2,1-2H3
94135-19-0Relevant articles and documents
Synthesis and biological activity of flavanone derivatives
Shi, Lei,Feng, Xiu E,Cui, Jing Rong,Fang, Lian Hua,Du, Guan Hua,Li, Qing Shan
scheme or table, p. 5466 - 5468 (2011/01/03)
A series of new flavanone derivatives of farrerol was synthesized by a convenient method. The in vitro anti-tumor activity of these compounds was evaluated against human Bel-7402, HL-60, BGC-823 and KB cell lines, the protein tyrosine kinase (PTK) inhibitor activity was also tested. Their cytoprotective activity was tested using hydrogen peroxide (H2O2)-induced injury in human umbilical vein endothelial cells. Their in vitro anti-atherosclerosis activity was tested on vascular smooth muscle cells by the MTT method using tetrandrine as a positive contrast drug. The structures of all compounds synthesized were confirmed by 1H, 13C NMR and ESI-MS. Most of the compounds exhibited good pharmacological activity and the preliminary structure-activity relationships were described.
